These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 27004972)

  • 41. Towards personalized therapy for patients with malignant melanoma: molecular insights into the biology of BRAF mutations.
    Bradish JR; Montironi R; Lopez-Beltran A; Post KM; MacLennan GT; Cheng L
    Future Oncol; 2013 Feb; 9(2):245-53. PubMed ID: 23414474
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Malignant Melanoma of Vulva and Vagina: A Histomorphological Review and Mutation Analysis--A Single-Center Study.
    Rouzbahman M; Kamel-Reid S; Al Habeeb A; Butler M; Dodge J; Laframboise S; Murphy J; Rasty G; Ghazarian D
    J Low Genit Tract Dis; 2015 Oct; 19(4):350-3. PubMed ID: 26225944
    [TBL] [Abstract][Full Text] [Related]  

  • 43. KIT gene mutations and copy number in melanoma subtypes.
    Beadling C; Jacobson-Dunlop E; Hodi FS; Le C; Warrick A; Patterson J; Town A; Harlow A; Cruz F; Azar S; Rubin BP; Muller S; West R; Heinrich MC; Corless CL
    Clin Cancer Res; 2008 Nov; 14(21):6821-8. PubMed ID: 18980976
    [TBL] [Abstract][Full Text] [Related]  

  • 44. KIT amplification and gene mutations in acral/mucosal melanoma in Korea.
    Yun J; Lee J; Jang J; Lee EJ; Jang KT; Kim JH; Kim KM
    APMIS; 2011 Jun; 119(6):330-5. PubMed ID: 21569090
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD117 immunoexpression in oral and sinonasal mucosal melanoma does not correlate with somatic driver mutations in the MAPK pathway.
    Maldonado-Mendoza J; Ramírez-Amador V; Anaya-Saavedra G; Ruíz-García E; Maldonado-Martínez H; Fernández Figueroa E; Meneses-García A
    J Oral Pathol Med; 2019 May; 48(5):382-388. PubMed ID: 30873641
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Melanomas of unknown primary frequently harbor TERT-promoter mutations.
    Egberts F; Krüger S; Behrens HM; Bergner I; Papaspyrou G; Werner JA; Alkatout I; Haag J; Hauschild A; Röcken C
    Melanoma Res; 2014 Apr; 24(2):131-6. PubMed ID: 24463461
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeted next-generation sequencing of Japanese patients with sinonasal mucosal melanomas identifies frequent NRAS and CTNNB1 mutations.
    Tsushima N; Kano S; Hatanaka KC; Suzuki T; Hamada S; Idogawa H; Nakamaru Y; Suzuki M; Hatanaka Y; Homma A
    Auris Nasus Larynx; 2024 Apr; 51(2):313-319. PubMed ID: 37953090
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vulvar and vaginal melanoma: A unique subclass of mucosal melanoma based on a comprehensive molecular analysis of 51 cases compared with 2253 cases of nongynecologic melanoma.
    Hou JY; Baptiste C; Hombalegowda RB; Tergas AI; Feldman R; Jones NL; Chatterjee-Paer S; Bus-Kwolfski A; Wright JD; Burke WM
    Cancer; 2017 Apr; 123(8):1333-1344. PubMed ID: 28026870
    [TBL] [Abstract][Full Text] [Related]  

  • 49. BRAF and NRAS prognostic values in conjunctival melanoma: analysis and literature review.
    Valentín-Bravo FJ; Pérez-Rodríguez Á; García-Álvarez C; García-Lagarto E; Saornil-Álvarez MA
    Arq Bras Oftalmol; 2023; 86(5):e20230071. PubMed ID: 35544941
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The clinical significance of BRAF and NRAS mutations in a clinic-based metastatic melanoma cohort.
    Ekedahl H; Cirenajwis H; Harbst K; Carneiro A; Nielsen K; Olsson H; Lundgren L; Ingvar C; Jönsson G
    Br J Dermatol; 2013 Nov; 169(5):1049-55. PubMed ID: 23855428
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TERT promoter mutations in melanoma survival.
    Nagore E; Heidenreich B; Rachakonda S; Garcia-Casado Z; Requena C; Soriano V; Frank C; Traves V; Quecedo E; Sanjuan-Gimenez J; Hemminki K; Landi MT; Kumar R
    Int J Cancer; 2016 Jul; 139(1):75-84. PubMed ID: 26875008
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinics, prognosis and new therapeutic options in patients with mucosal melanoma: A retrospective analysis of 75 patients.
    Schaefer T; Satzger I; Gutzmer R
    Medicine (Baltimore); 2017 Jan; 96(1):e5753. PubMed ID: 28072717
    [TBL] [Abstract][Full Text] [Related]  

  • 53. KIT, NRAS, and BRAF mutations in nail apparatus melanoma.
    Dika E; Altimari A; Patrizi A; Gruppioni E; Fiorentino M; Piraccini BM; Misciali C; Barisani A; Fanti PA
    Pigment Cell Melanoma Res; 2013 Sep; 26(5):758-60. PubMed ID: 23782496
    [No Abstract]   [Full Text] [Related]  

  • 54. Multiplex ligation-dependent probe amplification of conjunctival melanoma reveals common BRAF V600E gene mutation and gene copy number changes.
    Lake SL; Jmor F; Dopierala J; Taktak AF; Coupland SE; Damato BE
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5598-604. PubMed ID: 21693616
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Late Solitary Extraocular Recurrence From Previously Resected Iris Melanoma.
    Fabian ID; Thaung C; AlHarby L; Sisley K; Mudhar HS; Doherty RE; Stacey AW; Arora AK; Cohen VML; Sagoo MS
    Am J Ophthalmol; 2017 Sep; 181():97-105. PubMed ID: 28673748
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of molecular abnormalities in vulvar and vaginal melanomas.
    Aulmann S; Sinn HP; Penzel R; Gilks CB; Schott S; Hassel JC; Schmidt D; Kommoss F; Schirmacher P; Kommoss S
    Mod Pathol; 2014 Oct; 27(10):1386-93. PubMed ID: 24603591
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Melanocytomas of the central nervous system: a clinicopathological and molecular study.
    Wang H; Zhang S; Wu C; Zhang Z; Qin T
    Eur J Clin Invest; 2013 Aug; 43(8):809-15. PubMed ID: 23683178
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Vulvar melanoma].
    Chokoeva A; Tchernev G; Wollina U
    Akush Ginekol (Sofiia); 2015; 54(2):56-60. PubMed ID: 25909143
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma.
    Hintzsche JD; Gorden NT; Amato CM; Kim J; Wuensch KE; Robinson SE; Applegate AJ; Couts KL; Medina TM; Wells KR; Wisell JA; McCarter MD; Box NF; Shellman YG; Gonzalez RC; Lewis KD; Tentler JJ; Tan AC; Robinson WA
    Melanoma Res; 2017 Jun; 27(3):189-199. PubMed ID: 28296713
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mucosal melanomas of the head and neck: new aspects of the clinical outcome, molecular pathology, and treatment with c-kit inhibitors.
    Papaspyrou G; Garbe C; Schadendorf D; Werner JA; Hauschild A; Egberts F
    Melanoma Res; 2011 Dec; 21(6):475-82. PubMed ID: 21897303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.